Psilocybin & OCD: Mechanisms, Clinical Trials, and Rapid Relief
Explore mushroom research and guides on psilocybin & ocd: mechanisms, clinical trials, and rapid relief.
How Psilocybin Disrupts Obsessive-Compulsive Cycles
OCD involves a stuck brain feedback loop. Psilocybin disrupts it via 5-HT2A activation and neuroplastic rewiring that outlasts the drug's presence.
Psilocybin for OCD: Breaking the Loop
A 2026 RCT found 73.3% of OCD patients responded to weekly psilocybin, 40% achieved remission. Here's what the clinical evidence shows and where trials stand.
Psilocybin OCD Clinical Trials: Current Status and Results
Every published psilocybin OCD clinical trial compared: the 2006 Moreno pilot, the 2025 Pellegrini study, and the 2026 RCT showing 73.3% response rate.